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Summary
Background: Some lateral cervical lymphadenopathies may lead to the discovery of papillary
microcarcinomas (PMC) of the thyroid that are not radiologically apparent. This relatively
rare clinical situation raises questions about the diagnostic approach to chronic cervical lym-
phadenopathy and the impact of lymph node metastasis on PMC prognosis.
Purpose of the article: To study the epidemiologic, clinical, and prognostic criteria of cases of
lymphadenopathy that signaled PMC.
Patients and methods: A retrospective study of 167 consecutive cases of PMC compared with
13 cases where a cervical mass signaled other forms of PMC.
Results: The mean age was 48.5 years, the ratio of men to women was 5:8, and the mean
PMC size was 5.5mm. These data did not differently signiﬁcantly from those of the other
PMC cases. The preoperative imaging found ﬂuid content in six cases, with microcalciﬁca-
tions in three cases. All cases were treated by modiﬁed radical neck dissection on the side
with the lymphadenopathy and total thyroidectomy with central neck dissection. The lym-
phadenopathy included a ruptured capsule in ﬁve cases and was accompanied by central
lymph node metastases in three cases. Thyroid capsule involvement was signiﬁcantly more
common in cases of PMC discovered due to lymphadenopathy than in other cases of PMC
(69% versus 9.7%, respectively; p < 0.001). The mean follow-up was 7.3 years. There were
no deaths due to PMC signaled by lymphadenopathy. Two cases of lymph node recurrence
after 8 and 10 years were controlled by another surgery and radioactive iodine treatment.
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Conclusion: Any chronic cervical mass should suggest the possibility of thyroid origin, especially
in cases with cystic content or microcalciﬁcations in subjects with no particular risk factors.
An ultrasound of the thyroid should be done, as well as a ﬁne needle aspiration biopsy of
the lymphadenopathy with a thyroglobulin assay. Treatment is the same as for any thyroid
carcinoma, and results in a good oncological outcome, despite the possibility of lymph node
recurrences.
r Masson SAS.
I
T
i
(
a
o
i
c
p
t
l
m
a
c
t
P
e
c
P
T
r
f
d
s
c
p
c
u
l
c
t
t
t
s
w
P
s
a
d
S
s
c
Figure 1 Cervical ultrasound. Partially cystic mass measuring
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ntroduction
he incidence of thyroid cancer in France
s 2.5 per 100,000 (Francim cancer network
http://www.invs.sante.fr/surveillance/cancers/surveill-
nce cancers.htm). The incidence of clinical and/or radi-
logical lymphadenopathy at the time of cancer diagnosis
s estimated at 20 to 25% for all sizes of thyroid tumors
ombined [1,2]. In 7 to 13% of cases [3], cervical lym-
hadenopathies lead to the discovery of thyroid cancer
hat is not clinically or radiologically apparent. These
ymph node metastases thus signal subclinical papillary
icrocarcinoma (PMC) (< 1 cm: pT1a, UICC 2002).
This relatively rare clinical situation raises questions
bout the diagnostic approach in cases of chronic cervi-
al lymphadenopathy with no apparent primary tumor and
he impact of lymph node metastasis on the prognosis of
MC.
The purpose of this article is therefore to study the
pidemiologic, clinical, and prognostic criteria of cases of
ervical lymphadenopathy that signal subclinical PMC.
atients and methods
his single-center series of 342 cases of differentiated thy-
oid cancer of follicular cell origin, treated consecutively
rom 1985 to 2007, included 167 cases of microcarcinoma,
eﬁned as a papillary carcinoma less than or equal to 1 cm in
ize, according to the histopathology report. After excluding
linically suspected cases of thyroid tumor and those with a
ositive ﬁne-needle aspiration biopsy, we found 15 cases of
ervical lymphadenopathy with no suspicious thyroid nod-
le. In two cases, these were discovered histologically after
ymph node dissection for another tumor, one epidermoid
arcinoma of the ﬂoor of the mouth and one melanoma of
he face. Because these two cases did not meet the cri-
eria for this study, they too were excluded. This analysis
hus includes 13 cases of lymphadenopathy that signaled
ubclinical thyroid cancer.
The epidemiological, clinical, and histopathological data
ere recorded and compared with those for the rest of the
MC population, i.e., 154 other cases.
The data were input and analyzed with Excel®
oftware (Microsoft Corp., WA). The descriptive vari-
bles were expressed as means and their standard
eviations. The parametric data were compared with
tudent’s t test, and the proportions with a chi-
quare test. A value of p≤ 0.05 was considered signiﬁ-
ant.
A
o8× 10mm with intracystic vegetation and microcalciﬁcations
arrow). Note the high width-to-length ratio.
esults
able 1 summarizes the comparison of the 13 cases of lym-
hadenopathy that signaled PMC with the other types of
MC.
linical presentation
he mean age of these patients was 48.5 years (13—76
ears). The ratio of men to women was 5:8. A ﬁne-needle
spiration biopsy was done in three cases and was positive
n one case, negative in one, and ambiguous in the other.
hyroglobulin assays of the aspirated material were never
equested. There were no clinical signs of dysthyroidism or
hyroid autoimmunity. The ultrasound (performed in 11 of 13
ases) showed a mass that was totally cystic in two cases, of
ixed content in four cases (Fig. 1), and solid in ﬁve cases.
here weremicrocalciﬁcations in three cases. A CT scan with
ontrast was requested in three cases (Figs. 2 and 3) and an
RI in one case of a totally cystic mass (Fig. 3).
The lymphadenopathy was mapped at level III in ﬁve
ases, IIa in six, and IV in two.
The mean lymph node progression time could not bell cases underwent an exploratory cervicotomy with intra-
perative pathological examination. In three cases the
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Table 1 Clinical and pathology data from cases of PMC signaled by LAP and other cases of PMC.
Subclinical PMC
discovered due to
LAP n = 13
Other
microcarcinoma
n = 154
p value
Mean age 48.5 years 41.1 years > 0.1
Sex ratio 0.62 0.45 > 0.1
Size of PMC 5.5mm 5.9mm >0.1
Thyroid capsule involvement 9/13 (69%) 15/154 (9.7%) < 0.001*
Multifocal 2/13 (15.3)
Lymph node recurrence 2 cases
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tion = 5.6). There were two cases of lymph node recurrence,Figure 2 Cervical CT scan with contrast. Partially cystic left
level III conﬂuent lymphadenopathies (arrow).
immediate pathology of the cervical mass was inconclusive
and the thyroidectomy was performed after conclusive test-
ing. In 10 cases, the thyroidectomy was done at the same
time as the lymph node surgery. All cases were ultimately
treated by total thyroidectomy, central neck dissection, and
2
r
m
Figure 3 Axial cervical CT scan with contrast (A) and T2-we20/154 (12.9%) > 0.1
1 case > 0.1
ateral dissection on the side with the signal lymph node.
or six patients, only the lateral compartment was involved,
hile three had an associated lymphadenopathy of the cen-
ral compartment. The lymph node capsule ruptured in ﬁve
atients.
The mean size of the PMC foci (largest focus in mul-
ifocal cases) was 5.5mm (standard deviation = 2.7mm,
ange: 2—7mm). The primary tumors were unifocal unilobar,
xcept in two cases — one bifocal unilobar and one bilobar
3 foci). Mapping showed PMC by the upper pole in six cases,
he lower pole in one, and in the central lobe in ﬁve more.
In one case, no neoplastic focus could be found in the
hyroid. The thyroid capsule was penetrated in eight of 13
ases, and inﬁltrated but not penetrated in one other case,
or capsular involvement in nine of 13 cases (69.2%). Tumor
ncapsulation was not studied due to lack of details in the
ldest histopathology reports.
The tumor subtype was papillary in six cases, mixed
apillary-follicular in six cases, and no tumor in one case.
djuvant treatment and outcome
ostoperative treatment included radioactive iodine treat-
ent in all cases, twice in two cases and three times in
nother. The follow-up time was 7.3 years (standard devia-and 12 years after the initial treatment. The ﬁrst patient
equired a repeat dissection and 1 radioactive iodine treat-
ent, and the second two radioactive iodine treatments.
ighted coronal cervical MRI (B), cystic left level IV mass.
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hese two patients were followed for 8 and 10 years, respec-
ively, after the recurrence. The other patients had no
ocal/regional or remote relapses after a mean follow-up
f 8 years (standard deviation = 7.9 years).
iscussion
lateral cervical mass should always suggest the possibility
f lymph node metastasis of, ﬁrstly and depending on the
lcohol and tobacco use, epidermoid carcinoma of the upper
I and respiratory tracts. The second most common form is
hyroid cancer [4,5], particularly in subjects under 40 years
f age with no other risk factor, especially in cases of a cystic
ervical mass. In that situation, a clinical presentation of
he second branchial cleft cyst leads to a diagnosis of cystic
etastasis of thyroid cancer in one of 10 cases [6]. Such
ystic metastases were reported in a population with a mean
ge of 30 years [7], versus 48 years in our series. The course
f the disease is usually long — from several months to a few
ears, with cases reported at up to 14 years (cystic form) [8].
There is usually a single lymph node mass, mapped pre-
ominantly in the superior and median cervical levels IIa
nd III [2,6,9]. Involvement of the external jugular group
as been reported [10]. On imaging, some elements are sug-
estive of a diagnosis of thyroid metastasis. The ultrasound
hows a heterogeneous echogenic mass with microcalciﬁ-
ations [11]. According to Senchenkov et al., sphericity of
he lymph node, assessed by an elevated transverse-to-
ongitudinal dimension ratio, is very suggestive, together
ith cortical heterogeneity and multiple cystic areas [12].
n predominantly cystic forms, the presence of intracys-
ic hyperechoic elements [13,14] is consistently reported,
s described here (Fig. 1). The CT scan with contrast also
rovides speciﬁc signs, including central necrosis, a cystic
omponent, peripheral contrast uptake greater than in the
uscle, and calciﬁcations (Som’s criteria) [15]. Based on an
nalysis of these criteria, Ahn et al. report that such CT
as 100% sensitivity and 90% speciﬁcity, compared with 80%
or ultrasound [1]. The MRI shows a T2 hyperintense signal,
ndicating content rich in thyroglobulin [16]. The sensitivity
f ﬁne-needle aspiration biopsy was 66% [17]. The speciﬁc
ytological signs are presence of papillae, nuclear grooves,
ntranuclear cytoplasmic inclusions, and psammoma bodies
18]. The sensitivity of the thyroglobulin assay of the ﬁne
eedle aspiration ﬂuid is close to 100% [19—22].
In an initial lymph node metastasis situation, thyroid
bnormalities are discovered during the workup in 75% of
ases, primarily by ultrasound [2]. This is thus an essen-
ial test in a workup for chronic lymphadenopathy in young
dults.
However, as presented in this series, the workup as a
hole may be negative. It is in that particular situation,
fter fully informing the patient, that an exploratory cer-
icotomy with an immediate pathological examination may
e done. The diagnosis of lymph node metastasis suggested
y the ﬁne needle aspiration biopsy and the dark blue color
f the mass [7] is conﬁrmed by immediate pathologic eval-
ation (74% in this series). Thus a complete lateral and
entral dissection is performed along with a total thyroidec-
omy [17]. The histological form most commonly found in
he thyroidectomy specimen is papillary carcinoma of fol-R. Garrel et al.
icular origin. Rare cases of medullary (C cell) carcinoma
ave been reported [23,24]. The size of the primary tumor
s small — between 2 and 8mm (mean = 3.6mm) [10], 5.5mm
n our series. In the literature, there is nothing speciﬁc about
he number of tumor foci or the localization in the thyroid.
here was a single focus in the vast majority of cases [10].
ompartmental involvement is found in nearly one of two
ases according to Monchik et al. [7] (seven of 13 cases
n this series). When no deﬁnitive diagnosis can be made
ased on the histopathology, the procedure is limited to a
ymphadenectomy and then completed in a second proce-
ure. 131I remnant ablation is the rule [25]. Prognosis seems
ontroversial: Coleman reports a good prognosis [17], while
thers report a 28% rate of lateral lymph node recurrence
fter dissection [7]. In our series, two patients experienced
cervical lymph node recurrence at level IVb in one case and
Ib in another, both with initial capsule rupture — a poten-
ially poor prognostic factor. However, patients should be
ollowed for more than 20 years, since recurrences some-
imes occur very late.
onclusion
hen there is a lateral cervical cystic mass in a subject
nder 40 years of age who has no other risk factor, a thyroid
rigin should be considered. A ﬁne-needle aspiration biopsy
f the mass should be done, and possibly a thyroglobulin
ssay.
Immediate pathologic examination, while difﬁcult, does
rovide a diagnosis. In that speciﬁc situation, in a duly
nformed patient, a total thyroidectomy with central and
omolateral cervical lymph node dissection is recom-
ended. Radioisotope remnant ablation makes it possible to
roperly monitor tumor progression by post-ablation scintig-
aphy, together with Tg levels and anti-Tg antibody titers.
he prognosis is usually favorable, except in a few cases
here a lymph node recurrence may occur, even more than
0 years after treatment, particularly in patients with an
nitial cervical lymph node rupture.
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